Pharmaceutical

ConcertAI and Bayer to boost precision oncology with AI and ML insights

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.

Apr 24, 2025 - 06:00
ConcertAI and Bayer to boost precision oncology with AI and ML insights
ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.
Read the original article

Tags:

Previous Article

Boehringer to expand oncology presence with $572m Tessellate Bio deal

Next Article

TNF and Renova Health use AI to identify patients for GLP-1 treatments

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

BridgeBio gears up for FDA review of acoramidis following Phase III results

BridgeBio gears up for FDA review of acoramidis followi...

Jan 11, 2024

FSD Pharma names Zeeshan Saeed as new CEO

FSD Pharma names Zeeshan Saeed as new CEO

Jul 5, 2023

Opinion: Do chatbots have more time to be empathetic than physicians?

Opinion: Do chatbots have more time to be empathetic th...

May 17, 2023